» Articles » PMID: 34205662

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study

Overview
Journal J Pers Med
Date 2021 Jul 2
PMID 34205662
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Guided by the Conceptual Model of Implementation Research, we explored the acceptability, appropriateness, and feasibility of: (1) automated screening approaches utilizing existing health data to identify those who require subsequent diagnostic evaluation for familial hypercholesterolemia (FH) and (2) family communication methods including chatbots and direct contact to communicate information about inherited risk for FH. Focus groups were conducted with 22 individuals with FH (2 groups) and 20 clinicians (3 groups). These were recorded, transcribed, and analyzed using deductive (coded to implementation outcomes) and inductive (themes based on focus group discussions) methods. All stakeholders described these initiatives as: (1) acceptable and appropriate to identify individuals with FH and communicate risk with at-risk relatives; and (2) feasible to implement in current practice. Stakeholders cited current initiatives, outside of FH (e.g., pneumonia protocols, colon cancer and breast cancer screenings), that gave them confidence for successful implementation. Stakeholders described perceived obstacles, such as nonfamiliarity with FH, that could hinder implementation and potential solutions to improve systematic uptake of these initiatives. Automated health data screening, chatbots, and direct contact approaches may be useful for patients and clinicians to improve FH diagnosis and cascade screening.

Citing Articles

Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study.

Campbell-Salome G, Morgan K, Gabriel J, McGowan M, Walters N, Brangan A J Clin Lipidol. 2024; 18(5):e832-e843.

PMID: 39278768 PMC: 11606789. DOI: 10.1016/j.jacl.2024.07.011.


Applications of machine learning in familial hypercholesterolemia.

Luo R, Wang J, Hu L, Fu Q, Zhang S, Jiang L Front Cardiovasc Med. 2023; 10:1237258.

PMID: 37823179 PMC: 10562581. DOI: 10.3389/fcvm.2023.1237258.


International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.

Watts G, Gidding S, Hegele R, Raal F, Sturm A, Jones L Nat Rev Cardiol. 2023; 20(12):845-869.

PMID: 37322181 DOI: 10.1038/s41569-023-00892-0.


Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study.

Walters N, Lindsey-Mills Z, Brangan A, Savage S, Schmidlen T, Morgan K PEC Innov. 2023; 2:100134.

PMID: 37214500 PMC: 10194298. DOI: 10.1016/j.pecinn.2023.100134.


Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.

Jones L, Calvo E, Campbell-Salome G, Walters N, Brangan A, Rodriguez G Front Health Serv. 2023; 3:1104311.

PMID: 37188259 PMC: 10175779. DOI: 10.3389/frhs.2023.1104311.


References
1.
Pearson N, Naylor P, Ashe M, Fernandez M, Yoong S, Wolfenden L . Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020; 6(1):167. PMC: 7603668. DOI: 10.1186/s40814-020-00634-w. View

2.
Myers K, Knowles J, Staszak D, Shapiro M, Howard W, Yadava M . Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data. Lancet Digit Health. 2020; 1(8):e393-e402. PMC: 8086528. DOI: 10.1016/S2589-7500(19)30150-5. View

3.
Gale N, Heath G, Cameron E, Rashid S, Redwood S . Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013; 13:117. PMC: 3848812. DOI: 10.1186/1471-2288-13-117. View

4.
Abul-Husn N, Manickam K, Jones L, Wright E, Hartzel D, Gonzaga-Jauregui C . Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016; 354(6319). DOI: 10.1126/science.aaf7000. View

5.
Rahimian F, Salimi-Khorshidi G, Payberah A, Tran J, Ayala Solares R, Raimondi F . Predicting the risk of emergency admission with machine learning: Development and validation using linked electronic health records. PLoS Med. 2018; 15(11):e1002695. PMC: 6245681. DOI: 10.1371/journal.pmed.1002695. View